Phase 1 TAK-925 Study in Healthy Adult and Elderly Volunteers and Participants With Narcolepsy

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

November 4, 2017

Primary Completion Date

September 4, 2018

Study Completion Date

September 4, 2018

Conditions

Healthy Participants and Patients With Narcolepsy

Interventions

DRUG

TAK-925

TAK-925 Intravenous Infusion

DRUG

Placebo

TAK-925 Placebo Intravenous Infusion

Trial Locations (3)

Sumida Hospital, Sumida-ku

Hakata Clinic, Fukuoka

PS Clinic, Fukuoka